Latest news
Latest news
Here you can explore the latest news on pancreatic cancer, the charity, and our supporters.
The content you will find here includes updates, and insights that help raise awareness and support our mission in the fight against pancreatic cancer.
Life-extending pancreatic cancer drug finally wins NICE approval
We are absolutely delighted to announce that NICE has given the green light to Abraxane®, a drug that can extend the lives of pancreatic cancer patients. This means that patients in England will be able to have access to the drug.
Read more
New recipe book launched for pancreatic cancer patient
Pancreatic Cancer Action has launched a recipe book to help alleviate one of the key side effects of pancreatic cancer: the inability to maintain weight and a nutritional balance.
Read more
Reappraisal of life-extending drug Abraxane
NICE, the institute that provides national guidance and advice to improve health and social care in England and Wales, will reappraise Abraxane® for treating metastatic pancreatic cancer.
Read more
10 year survival rates improving for most cancers but sadly not pancreatic cancer
On World Cancer Day, Cancer Research UK released new statistics to show that cancer deaths are falling with ten year survival rates of some cancers improving significantly since 1971.
Read more
Obesity increases pancreatic cancer risk
You may have seen in the news today that the ‘obesity epidemic’ could lead to an additional 670,000 cancer cases over the next 20 years, including pancreatic cancer.
Read more
Abraxane (nab-paclitaxel) plus gemcitabine shown to improve survival in metastatic pancreatic cancer
Celgene UK and Ireland's Phase III trial shows Abraxane plus gemcitabine significantly improves survival in metastatic pancreatic cancer patients.
Read more